yellow
fever
yf
import
public
health
concern
area
diseas
endem
year
highli
effect
live
attenu
vaccin
avail
widespread
use
result
dramat
decreas
number
case
rare
occas
yf
vaccin
caus
mild
sever
diseas
rare
advers
vaccineassoci
event
report
addit
averag
viremia
day
administr
yf
vaccin
publish
present
case
yf
vaccin
isol
cell
cultur
respiratori
swab
collect
patient
present
influenzalik
ill
best
knowledg
first
report
find
replic
yf
vaccin
respiratori
sampl
post
inocul
individu
elsevi
bv
right
reserv
influenzalik
ill
ili
major
health
issu
winter
month
temper
climat
caus
larg
rang
pathogen
includ
influenza
rhinoviru
human
metapneumoviru
parainfluenza
virus
bacteria
use
cultur
detect
respiratori
pathogen
becam
increasingli
common
clinic
virolog
laboratori
last
year
commerci
avail
cell
cultur
howev
introduct
commerci
manufactur
fdaapprov
molecular
assay
includ
multiplex
pcr
assay
prefer
test
viral
pathogen
use
cell
cultur
system
diminish
case
studi
describ
util
cell
cultur
follow
electron
microscopi
em
identifi
unknown
pathogen
caus
ili
healthi
year
old
woman
moreov
case
highlight
import
provid
relev
case
histori
order
avoid
unnecessari
test
year
old
femal
seen
colleg
student
health
clinic
present
fever
f
c
day
nausea
vomit
cough
myalgia
patient
histori
note
recent
travel
vaccin
anim
contact
insect
bite
ili
initi
diagnosi
respiratori
swab
sent
influenza
test
test
algorithm
includ
molecular
assay
convent
cell
cultur
respiratori
swab
inocul
primari
rhesu
monkey
kidney
cell
diagnost
hybrid
athen
oh
human
lung
adenocarcinoma
cell
human
embryon
lung
cell
hel
epitheli
colorect
adenocarcinoma
cell
inocul
cell
line
examin
cytopath
effect
cpe
three
time
week
week
parallel
primari
sampl
extract
use
easymag
test
influenza
b
use
center
diseas
control
prevent
cdc
human
influenza
viru
realtim
rtpcr
diagnost
panel
unpublish
protocol
detail
avail
cdc
request
influenza
b
respiratori
syncyti
viru
b
human
metapneumoviru
rhinoviru
enteroviru
parainfluenza
virus
human
coronavirus
qiagen
resplex
ii
kit
qiagen
germantown
md
multipl
realtim
rt
pcr
assay
use
detect
cytomegaloviru
epsteinbarr
viru
human
herpesviru
adenoviru
enteroviru
herp
simplex
viru
herp
simplex
viru
varicella
zoster
viru
rhinoviru
mycoplasma
pneumonia
legionella
pneumophila
chlamydia
pneumonia
unpublish
assay
provid
k
musser
cpe
observ
day
cell
cell
line
exhibit
viral
chang
total
day
incub
qiagen
resplex
ii
assay
realtim
rt
pcr
assay
neg
investig
agent
grown
cell
isol
extract
use
qiagen
viral
rna
mini
kit
test
panel
molecular
assay
use
primari
sampl
result
neg
time
submit
laboratori
contact
obtain
addit
patient
inform
may
elucid
could
propag
cell
cultur
clinician
report
noth
relev
note
histori
viru
cultur
prepar
shipment
cdc
em
briefli
mixtur
infect
scrape
cell
glutaraldehyd
centrifug
g
min
supernat
centrifug
adsorb
formvarcarbon
coat
grid
neg
stain
ammonium
trehalos
ph
subsequ
thinsect
electron
microscopi
perform
centrifug
cell
cultur
precipit
use
routin
method
similar
describ
previous
specimen
view
within
tecnai
biotwin
electron
microscop
oper
kv
fei
compani
hillsboro
imag
captur
digit
use
ccd
camera
advanc
microscopi
techniqu
corp
woburn
imag
observ
em
consist
either
togaviru
flaviviru
fig
b
consequ
observ
nucleic
acid
isol
amplifi
use
panflaviviru
convent
rtpcr
assay
target
portion
region
pcr
product
expect
size
sequenc
use
pcr
primer
result
sequenc
combin
blast
analyz
demonstr
highest
sequenc
similar
yf
viru
student
health
clinic
contact
discuss
patient
histori
provid
addit
inform
includ
administr
yf
vaccin
patient
day
prior
collect
origin
respiratori
specimen
also
patient
recov
character
yf
viru
publish
primer
primer
design
studi
use
geneiou
pro
biomatt
san
francisco
ca
use
sequenc
membran
envelop
e
gene
region
tabl
target
identifi
viru
highest
similar
yf
vaccin
multipl
paper
publish
advers
event
associ
yf
vaccin
howev
literatur
focus
viscerotrop
diseas
multisystem
organ
failur
mimic
wildtyp
diseas
progress
present
case
suffer
ili
fever
cough
eight
day
receiv
yf
vaccin
yf
vaccin
isol
cell
respiratori
swab
viru
prepar
stain
imag
em
identifi
sequenc
analysi
gene
addit
sequenc
analysi
e
gene
verifi
highest
ident
yf
vaccin
strain
revers
wildtyp
yf
viru
asibi
strain
present
yf
vaccin
highli
effect
vaccin
abil
greatli
decreas
incid
yf
peopl
travel
endem
area
despit
possibl
advers
event
risk
sever
event
postvaccin
low
http
wwwcdcgovvaccinespub
visdownloadsvisyfpdf
sinc
replic
yf
vaccin
isol
propag
cell
cultur
absenc
detect
known
infecti
agent
potenti
caus
ili
yf
vaccin
patient
receiv
day
previous
although
known
viremia
occur
day
inocul
yf
vaccin
first
report
knowledg
isol
yf
vaccin
respiratori
sampl
recent
vaccin
individu
case
highlight
import
collect
submiss
appropri
case
histori
ongo
avail
cell
cultur
electron
microscopi
assist
identif
unusu
unexpect
agent
em
cell
cultur
isol
util
identifi
mani
previous
unknown
unsuspect
virus
associ
diseas
outbreak
exampl
includ
zair
ebolaviru
reston
ebolaviru
hendra
viru
monkeypox
viru
sar
coronaviru
case
like
virus
mention
pathogen
detect
cell
cultur
subsequ
identifi
em
without
assist
em
relev
molecular
assay
would
chosen
identifi
viru
fund
provid
within
wadsworth
center
perform
studi
